The Role of Complement C3a Receptor in Stroke
- 17 May 2019
- journal article
- review article
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 21 (4) , 467-473
Abstract
The complement system is a key regulator of the innate immune response against diseased tissue that functions across multiple organ systems. Dysregulation of complement contributes to the pathogenesis of a number of neurological diseases including stroke. The C3a anaphylatoxin, via its cognate C3a receptor (C3aR), mediates inflammation by promoting breakdown of the blood–brain barrier and the massive infiltration of leukocytes into ischemic brain in experimental stroke models. Studies utilizing complement deficient mice as well as pharmacologic C3aR antagonists have shown a reduction in tissue injury and mortality in murine stroke models. The development of tissue-specific C3aR knockout mice and more specific C3aR antagonists is warranted to facilitate our understanding of the role of the C3aR in brain ischemia with the ultimate goal of clinical translation of therapies targeting C3aR in stroke patients.Keywords
Funding Information
- Barrow Neurological Foundation (start up, trainee grant)
This publication has 70 references indexed in Scilit:
- Overview of Complement Activation and RegulationSeminars in Nephrology, 2013
- Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic‐ischemic brain injuryThe FASEB Journal, 2013
- Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused StrokePLOS ONE, 2012
- The Potential of Tetrandrine as a Protective Agent for Ischemic StrokeMolecules, 2011
- Complement in the brainMolecular Immunology, 2011
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyThe American Journal of Pathology, 2011
- Pathophysiology, treatment, and animal and cellular models of human ischemic strokeMolecular Neurodegeneration, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Complement in neuroprotection and neurodegenerationTrends in Molecular Medicine, 2010
- Neuroprotection in stroke by complement inhibition and immunoglobulin therapyNeuroscience, 2009